Hepatitis E Hepatitis E  HEV can be clustered genetically into 8 genotypes, and genotypes 3 and 4 tend to be the ones that cause chronic hepatitis in the immunosuppressed. In 2017, hepatitis E was estimated to affect more than 19 million people.  Those most commonly at risk of HEV are men aged 15 to 35 years of age.  A preventive vaccine  is approved for use in China. The average incubation period of hepatitis E is 40 days, ranging from 2 to 8 weeks.  After a short prodromal phase symptoms may include jaundice, fatigue, and nausea, though most HEV infections are asymptomatic.  The symptomatic phase coincides with elevated hepatic aminotransferase levels Hepatitis E Hepatitis E